These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7031140)

  • 1. An immunofluorescence assay for complement activation by the classical pathway.
    Linder E; Rhen M; Meri S
    J Immunol Methods; 1981; 47(1):49-59. PubMed ID: 7031140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-independent binding and activation of complement by Schistosoma mansoni adult worms.
    Linder E; Huldt G
    Parasite Immunol; 1983 Mar; 5(2):183-94. PubMed ID: 6601790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation by C-reactive protein on the HEp-2 cell substrate.
    Vaith P; Prasauskas V; Potempa LA; Peter HH
    Int Arch Allergy Immunol; 1996 Oct; 111(2):107-17. PubMed ID: 8859218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
    Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
    Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry based detection of HLA alloantibody mediated classical complement activation.
    Wahrmann M; Exner M; Regele H; Derfler K; Körmöczi GF; Lhotta K; Zlabinger GJ; Böhmig GA
    J Immunol Methods; 2003 Apr; 275(1-2):149-60. PubMed ID: 12667679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of C1q and complement activation by vascular endothelium.
    Linder E
    J Immunol; 1981 Feb; 126(2):648-58. PubMed ID: 7451988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro complement activation by intercellular antibodies.
    Hashimoto T; Sugiura M; Kurihara S; Nishikawa T
    J Invest Dermatol; 1982 Apr; 78(4):316-8. PubMed ID: 6978365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG binding to cytoskeletal intermediate filaments activates the complement cascade.
    Hansson GK; Lagerstedt E; Bengtsson A; Heideman M
    Exp Cell Res; 1987 Jun; 170(2):338-50. PubMed ID: 3496230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid phase enzyme linked immunosorbent assay for classical complement activation pathway.
    Rhen M
    J Clin Pathol; 1987 Feb; 40(2):237-9. PubMed ID: 2434532
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for deficiencies in the classical and alternative pathways of complement by hemolysis in gel.
    Truedsson L; Sjöholm AG; Laurell AB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):161-6. PubMed ID: 7032205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
    Gullstrand B; Mårtensson U; Sturfelt G; Bengtsson AA; Truedsson L
    Clin Exp Immunol; 2009 May; 156(2):303-11. PubMed ID: 19302245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
    Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
    Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternate and classical pathway components of complement in the normal cornea.
    Mondino BJ; Ratajczak HV; Goldberg DB; Schanzlin DJ; Brown SI
    Arch Ophthalmol; 1980 Feb; 98(2):346-9. PubMed ID: 6766301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-independent binding of Clq and activation of serum complement by human skin in vitro.
    Linder E
    J Invest Dermatol; 1982 Feb; 78(2):116-20. PubMed ID: 7035571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.